Mei Tang

Dr. Mei Tang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in Archives of Medical Science
Verified
Journal Article
Open access
GWGang Wang
Gang Wang
NZNing Zhuo
Ning Zhuo
MTMei Tang
Mei Tang
LXLeixi Xue
Leixi Xue
ZLZhichun Liu
Zhichun Liu

12 December 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SCShanshan Chen
Shanshan Chen
LZLin Zhang
Lin Zhang
MYMengxue Yan
Mengxue Yan
SLSiping Li
Siping Li
LXLeixi Xue
Leixi Xue
MTMei Tang
Mei Tang
Objectives: This study aimed to explore the association of low complement items with the performance of the systemic lupus erythematosus (SLE) classification criteria. Methods: This study included 352 patients with SLE and 385 individuals with positive antinuclear antibodies with other diseases. The performance of the Systemic Lupus International Collaborating Clinics (SLICC)-2012, European League Against Rheumatism and American College of Rheumatology (EULAR/ACR)-2019, and SLE Risk Probability Index (SLERPI) were compared before and after excluding the low complement item. Results: The exclusion of the low complement item decreased the sensitivity and increased the specificity of SLICC-2012 and EULAR/ACR-2019, whereas SLERPI demonstrated stable classification performance in classifying patients with and without SLE. SLICC-2012 exhibited the highest sensitivity in identifying patients with SLE with hypocomplementemia (99.0%; 95% confidence interval [CI]: 97.2–99.8%), followed by SLERPI (98.4%; 95% CI: 96.3–99.5%) and EULAR/ACR-2019 (97.7%; 95% CI: 95.4–99.1%). After excluding the low complement item, the sensitivities decreased to 93.0% (89.5–95.5%) for SLICC-2012, 97.5% (86.8–99.9%) for SLERPI, and 93.3% (90.0–95.8%) for EULAR/ACR-2019. SLICC-2012, EULAR/ACR-2019, and SLERPI identified 16, 17, and 21 patients with SLE with hypocomplementemia before clinical diagnosis, decreasing to 10, 16, and 20 cases after excluding the low complement item. Further, patients with SLE with both low C3 and C4 levels demonstrated shorter disease duration, higher acute cutaneous lupus prevalence, nonscarring alopecia, and increased positivity rates for anti-DNA antibodies, antiphospholipid antibodies, and direct Coombs’ tests compared with those with low C3 or C4 levels. The SLE group with low C3 and C4 levels demonstrated significantly higher total scores than the SLE group with low C3 or C4 levels in all three classification criteria, and this significance persisted even after excluding the low complement item. Conclusion: The low complement item strongly improved the sensitivity and early classification capacity of SLICC-2012 while minimally influencing SLERPI. Furthermore, higher weights assigned to combined low C3 and C4 levels in EULAR/ACR-2019 appear clinically justified.

17 February 2023 in Archives of Medical Science
Verified
Journal Article
Open access
PDF file
GWGang Wang
Gang Wang
MTMei Tang
Mei Tang
LXLeixi Xue
Leixi Xue
ZLZhichun Liu
Zhichun Liu